Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-064850
Filing Date
2024-05-24
Accepted
2024-05-24 20:00:08
Documents
1
Period of Report
2024-05-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5531
  Complete submission text file 0000950170-24-064850.txt   7069
Mailing Address 1600 SMITH STREET HQSEO HOUSTON TX 77002
Business Address
SMISEK JEFFERY A (Reporting) CIK: 0001193038 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40227 | Film No.: 24986015

Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 617-229-6499
Finch Therapeutics Group, Inc. (Issuer) CIK: 0001733257 (see all company filings)

EIN.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)